Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lymphoscintigraphy Assisted Molecular Staging of Head and Neck Cancer

NCT00012168 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00012168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00012168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lymphoscintigraphy Assisted Molecular Staging of Head and Neck Cancer
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Completed
Start date
May 31, 1999
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer